Significance of CD99 expression in T-lineage acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Significance of CD99 expression in T-lineage acute lymphoblastic leukemia

Published:2016-08-03 Issue:2 Volume:17 Page:117-123
ISSN:1574-0153
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Enein Azza A. Aboul¹,Rahman Hala A. Abdel¹,Sharkawy Nahla El²,Elhamid Samah Abd¹,Abbas Sonia M.A.³,Abdelfaatah Rafaat⁴,Khalil Mohamed²,Fathalla Lamiaa A.²

Affiliation:

1. Clinical and Chemical Pathology Department, Kasr Al Aini, Faculty of Medicine, Cairo University, Cairo, Egypt

2. Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt

3. Pediatric Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt

4. Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference14 articles.

1. Molecular-genetic insights in pediatric T-cell acute lymphoblastic leukaemia;Vlierberghe;British Journal of Haematology,2008

2. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease;Dworzak;Leukemia,2004

3. New definition of remission in childhood acute lymphoblastic leukemia;Pui;Leukemia,2000

4. Modulation of antigen expression in B-cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug-induced regulatory phenomenon. Results of the AIEOP-BFM-ALL-FLOW-MRD-Study Group;Dworzak;Cytometry B Clin Cytom,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-05

2. FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report;Cytometry Part A;2023-10-19

3. The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives;Experimental Hematology & Oncology;2023-01-09

4. Cell adhesion molecule CD99 in cancer immunotherapy;Current Molecular Medicine;2022-10-07

5. CD99 in malignant hematopoiesis;Experimental Hematology;2022-02